Core Viewpoint - The company has entered into a strategic cooperation framework agreement with Shenzhen Qianhai Pengfeng Industrial Technology Co., Ltd. to explore opportunities in the digital transformation and asset value enhancement of the traditional Chinese medicine industry [1] Group 1: Strategic Cooperation - The agreement aims to establish a long-term strategic partnership focusing on the digital upgrade and platform operation of the traditional Chinese medicine industry [1] - Key areas of collaboration include digitalization of physical assets, joint market expansion for traditional Chinese medicine and related products, and exploring multi-level capital cooperation including equity investment [1] Group 2: Business Operations and Expertise - The company primarily engages in financing leasing services for medical equipment, maternal and infant care services, and trade of medical devices and consumables in China [1] - The board believes that this strategic cooperation will enhance the company's capabilities in asset management and supply chain services without altering its existing core business [1] - The collaboration is expected to improve asset management efficiency and supply chain transparency in the field of traditional Chinese medicine [1] Group 3: Long-term Value Creation - Through synergy in technology, platforms, and market resources with the partner, the company aims to expand its business landscape in the healthcare and related supply chain service sectors [2] - The board considers the terms of the framework agreement to be fair and reasonable, aligning with the overall interests of the company and its shareholders [2]
紫元元(08223.HK)拟携手深圳前海鹏峰实业科技共同探索中药材产业数字化转型及资产价值提升